Moxetumomab Pasudotox

Fact of Medicine

Brand Name: Lumoxiti
Innovator Brand Name: Lumoxiti
API: Moxetumomab Pasudotox-tdfk
Packaging: 1 Vial (Per Box)
Strength: 1mg
Manufacturer Name: AstraZeneca

Get Price


Moxetumomab Medication:

Lumoxiti (Moxetumomab Pasudotox Injection) is a CD22-directed cytotoxin. It is used to treat adults with hairy cell leukemia (HCL): That has come back or has not responded to last treatment, and have received minimum two other treatments, including a type of drug named purine nucleoside analog (PNA).

Dosage: The recommended lumoxiti dosage is 0.04 mg/kg administered as a 30 minute intravenous infusion on Days 1’st, 3’rd, & 5’th of each 28-day cycle. Continue moxetumomab pasudotox treatment for a maximum of six cycles, until the disease is progressive, or unacceptable toxicity occurs.

Side Effects: The most commonly reported lumoxiti side effects may include:

  • Edema
  • Nausea
  • Fatigue
  • Headache
  • Pyrexia
  • Constipation
  • Anemia
  • Diarrhea
  • Infusion related reactions

Warnings and Precautions:

  • Patients on moxetumomab pasudotox should be monitored for fluid balance and serum electrolytes to avoid fluid overload or electrolyte abnormalities.
  • Patients taking lumoxiti 1 mg injection are advised to maintain adequate hydration throughout treatment.
  • Patients with the therapy of lumoxiti should be monitored for weight and blood pressure prior to each infusion during treatment.
  • Patients receiving lumoxiti dose must be monitored for renal function prior to each and every infusion throughout treatment.
  • Nursing women with lumoxiti injection are advised to avoid breastfeeding while on receiving this medication.

More info

Storage: Refrigerate Lumoxiti (Moxetumomab Pasudotox IV solution at temperature 2°C to 8°C (36°F to 46°F), in the original carton in order to protect from light. Neither freeze nor shake it. Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship LUMOXITI at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the LUMOXITI Injections. Buying Procedure: In order to buy LUMOXITI, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp number +919310090915 or an Email to us at: along with your Identity Proof, Legitimate Prescription Letter and Medical Reports. Conclusion: Moxetumomab Pasudotox, the first FDA approved CD22-directed cytotoxin, is a new treatment option for patients with a are type of leukemia named Relapsed/Refractory Hairy Cell Leukemia. This novel intravenously administered biologic drug has demonstrated complete as well as durable responses, along with acceptable tolerability, in recipients with relapsed or refractory Hairy Cell Leukemia.


What is Lumoxiti? Lumoxiti is a prescription medication used for the treatment of adult patients with hairy cell leukemia (HCL). What does Lumoxiti contain as an active substance? The medication Lumoxiti specifically contains the active substance Moxetumomab Pasudotox-tdfk. Is Moxetumomab Pasudotox-tdfk an FDA approved drug? Yes, Moxetumomab Pasudotox-tdfk is an FDA approved drug. How much does lumoxiti cost? The lumoxiti price in India usually may vary depending on the wholesaler/pharmacy you visit and of course the brand you choose. What is the best price of Moxetumomab Pasudotox? Please contact Toll-free: +91 1800 889 1064|+919310090915 for moxetumomab pasudotox price in India. We take guarantee of quality as well as delivery anywhere in the world as per the buyer’s requirements. Can I get Lumoxiti (Moxetumomab Pasudotox) even if I am not based in India? The Indian Pharma helps patients in accessing or importing Lumoxiti (Moxetumomab Pasudotox), not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.